#USA #healthcare #Dividend #Abbott #Abbott Park

Abbott's 407th Consecutive Quarterly Dividend Announcement

On September 19, 2025, Abbott (NYSE: ABT) proudly announced its 407th consecutive quarterly common dividend of 59 cents per share. This remarkable achievement underscores Abbott's long-standing commitment to providing value to its shareholders. Since 1924, the company has maintained a tradition of consistent dividend payments, marking a notable milestone in corporate governance and shareholder relations.

A Legacy of Consistency

Abbott's dividend announcement reflects a rich history characterized by financial discipline and a steadfast commitment to rewarding investors. Over the past 53 years, Abbott has consistently increased its dividend payouts, firmly establishing itself as a member of the prestigious S&P 500 Dividend Aristocrats Index. This index tracks companies that have successfully increased their dividends for at least 25 consecutive years. Abbott's inclusion in this elite group is a testament to its robust business model and strong financial performance.

Key Dates

The cash dividend will be payable on November 17, 2025, to shareholders who are officially recorded by the close of business on October 15, 2025. This structured timeline empowers investors to plan and manage their portfolios optimally, ensuring they reap the benefits of Abbott's commitment to shareholder returns.

Abbott's Global Impact

As a worldwide leader in healthcare, Abbott plays a crucial role in improving the quality of life for people around the globe. With a dedicated workforce of over 114,000 employees, the company operates across more than 160 countries, focusing on developing innovative technologies that span various healthcare domains. This includes not just diagnostics and medical devices but also nutritional products and branded generic medicines, all designed to cater to diverse healthcare needs.

Moreover, Abbott's commitment to innovation and improvement ensures that it remains at the forefront of healthcare transformation, continuously adapting to meet evolving global health challenges. As the company advances its initiatives in new product development and market expansion, its long-term growth prospects remain strong, bolstered by a sustained commitment to quality and innovation.

The Road Ahead

Abbott's board of directors continues to prioritize shareholder value while navigating the complexities of the global healthcare landscape. As the company moves forward, it will undoubtedly explore new avenues for growth while remaining committed to its foundational principles of integrity, innovation, and reliable dividend payments. The 407th consecutive quarterly dividend reinforces that commitment, instilling confidence in current and prospective investors alike.

Conclusion

As Abbott looks towards the future, it continues to honor its legacy through consistent shareholder returns while making significant strides in global healthcare solutions. The latest dividend declaration not only underscores Abbott's financial stability but also highlights its commitment to delivering on its promises to investors. Shareholders can be assured that they are part of a company that values their investment and is committed to creating a healthier tomorrow for people everywhere. For more information about Abbott and its ongoing initiatives, visit their official website at www.abbott.com.